Mian XI
Academic / Other · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401) Hepatocellular Carcinoma | Phase 2 | 2024-03-10 |
| Completed | Identification of Breath Biomarkers in Esophageal Cancer Esophageal Squamous Cell Carcinoma | — | 2022-09-27 |
| Unknown | Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01) Hepatocellular Carcinoma | Phase 2 / Phase 3 | 2019-11-16 |
| Completed | Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer Unresectable Esophageal Cancer | Phase 2 | 2019-06-25 |
| Unknown | PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Neoplasm, Esophageal, Squamous Cell Carcinoma | Phase 2 | 2019-01-15 |
| Completed | Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer Neoplasms | Phase 2 | 2015-05-01 |